1. Moradi F, Nabaei B, and Yeganeh B. The epidemiology of AIDS in Iran from beginning until now. Tehran University Medical Journal. 2000; 58(4): 79-88.
2. Golrokhi R., et al. HIV Prevalence and Correlations in Prisons in Different Regions of the World: A Review Article. The open AIDS journal. 2018; 12: 81-92. [
DOI:10.2174/1874613601812010081] [
PMID] [
PMCID]
3. UNAIDS. Fact sheet - global AIDS update 2019. Available from: https://www.unaids. org/en/resources/fact-sheet.
4. Seyed Alinaghi S.A., et al. Adherence to Antiretroviral Therapy and Tuberculosis Treatment in a Prison of Tehran, Iran. Infectious Disorders - Drug Targets. 2016; 16(3): 199-203. [
DOI:10.2174/1871526516666160616111308] [
PMID]
5. Khan M.D., et al. Prevalence and associated risk factors of HIV in prisons in Balochistan, Pakistan: a cross-sectional study. F1000Research. 2018.; 7: 1821. [
DOI:10.12688/f1000research.16994.1] [
PMID] [
PMCID]
6. Farhoudi B, et al.,Barriers to Adherence to Antiretroviral Treatment Among Inmates of a Prison in Tehran, Iran: A Qualitative Study. Archives of Clinical Infectious Diseases. 2018;13(2):e57911. [
DOI:10.5812/archcid.57911]
7. Farhoudi B, et al.,Revision and Implementation of "Clinical Guideline for Tuberculosis and HIV in Prisons", Great Tehran Prison, Iran. Infectious disorders drug targets. 2018;18(1): 72-80. [
DOI:10.2174/1871526517666170518093529] [
PMID]
8. SeyedAlinaghi S., et al. Evaluation of Stigma Index Among People Living With HIV/AIDS (PLWHA) in Six Cities in Iran. Thrita. 2013; 2(4):69-75. [
DOI:10.5812/thrita.11801]
9. Rintamaki L.S., et al. Social stigma concerns and HIV medication adherence. AIDS Patient Care and STDs. 2006; 20(5): 359-68. [
DOI:10.1089/apc.2006.20.359] [
PMID]
10. Emamzadeh-Fard S., et al. Adherence to anti-retroviral therapy and its determinants in HIV/AIDS patients: a review. Infectious Disorders - Drug Targets. 2012;12(5): 346-56. [
DOI:10.2174/187152612804142251] [
PMID]
11. Shalihu N., et al. Namibian prisoners describe barriers to HIV antiretroviral therapy adherence. AIDS Care. 2014; 26(8):968-75. [
DOI:10.1080/09540121.2014.880398] [
PMID]
12. Wasti S.P., et al. Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study. PLoS One. 2012;7(5): e35547. [
DOI:10.1371/journal.pone.0035547] [
PMID] [
PMCID]
13. Biadgilign S., et al. Barriers and facilitators to antiretroviral medication adherence among HIV-infected paediatric patients in Ethiopia: A qualitative study. SAHARA-J: Journal of Social Aspects of HIV/AIDS. 2009; 6(4): 148-54. [
DOI:10.1080/17290376.2009.9724943] [
PMID]
14. Kagee, A. and Delport T. Barriers to adherence to antiretroviral treatment: the perspectives of patient advocates. Journal of Health Psychology. 2010;15(7): 1001-11. [
DOI:10.1177/1359105310378180] [
PMID]
15. Mehraeen E., et al. Mobile-Based Applications and Functionalities for Self-Management of People Living with HIV. Studies in health technology and informatics. 2018;248: 172-179.
16. Wanyama J., et al. Belief in divine healing can be a barrier to antiretroviral therapy adherence in Uganda. Aids. 2007; 21(11):1486-7. [
DOI:10.1097/QAD.0b013e32823ecf7f] [
PMID]